Table 3

Correlations between MMPs, TIMPs, MPO and measures of infarct size

	Total LGE %LV at 5 days (n=58)	Total LGE %LV at 4 months (n=46)
MMP-2
0 h	0.460**	0.459**
12 h	0.543**	0.486**
24 h	0.133	0.061
48 h	0.099	0.134
MMP-8
0 h	0.043	0.088
12 h	−0.022	−0.069
24 h	−0.012	0.085
48 h	0.078	0.017
MMP-9
0 h	0.150	0.237
12 h	0.068	0.183
24 h	0.077	0.203
48 h	0.218	0.161
TIMP-1
0 h	0.064	0.085
12 h	0.219	0.074
24 h	0.378*	0.318*
48 h	0.312*	0.215
TIMP-2
0 h	0.341*	0.185
12 h	0.379*	0.277
24 h	0.069	−0.027
48 h	0.118	0.082
MPO
0 h	0.107	0.108
12 h	0.004	0.130
24 h	−0.047	0.117
48 h	0.140	0.227

*p<0.05, **p<0.01.
Values are given as ρ values from the Spearman test.
LGE, late gadolinium enhancement zone; LV, left ventricle; MMP, matrix metalloproteinase; MPO, myeloperoxidase; n, number of patients; TIMP, tissue inhibitor of metalloproteinase.